Thus, for the definitive diagnosis of pleomorphic liposarcoma, a consistent morphology (with demonstration of a pleomorphic sarcoma with presence of lipoblasts/lipoblastic differentiation) along with absence of MDM2 amplification (which would be rather consistent, if present, with dedifferentiated liposarcoma) is needed. The gene discussed is MDM2; the disease is liposarcoma.